Assessment of systemic and organotoxic effects caused by the modern synthetic opioids: clinical and forensic aspects

  • Authors: N.V. Kurdil, K.F. Voroshylov, O.N. Rozhkova, M.Yu. Voitenko, P.S. Novostroina, I.V. Rozovyk
  • UDC: 615.6+616–091.8:616–099
  • DOI: 10.33273/2663-4570-2023-94-1-7-20
Download attachments:

N. Kurdil1, K. Voroshilov2, O. Rozhkova2, M. Voytenko2, P. Novostroyna2, I. Rozovyk3

 

1L.I. Medved’s Research Center of Preventive Toxicology, Food and Chemical Safety, Ministry of Health, Ukraine (State Enterprise), Kyiv, Ukraine

2Municipal Іnstitution of the Kyiv Regional Council "Kyiv Regional Bureau of Forensic Medical Examination"

3State specialized Іnstitution "Main Bureau of Forensic Medical Examination of the Ministry of Health of Ukraine", Kyiv, Ukraine

 

ABSTRACT. Establishing the cause of death in modern drug poisonings (overdoses) is not always a simple task. The systemic toxic effects resulting from the consumption of opioid drugs of the new generations are extremely diverse and extend far beyond the nervous system. The causes of death and mechanisms of tonatogenesis are also quite diverse, so their establishment is based on a wide range of data that can be obtained both during life and in the process of forensic research.

Aim. Analysis of the causes of death due to drug poisoning (opioids-related) in adults according to the data of clinical and pathohistological studies.

Materials and Methods. A retrospective analysis of the medical records of 164 patients who died in the hospital as a result of opioid poisoning during the period 2017–2021 was carried out; analyzed the data of sectional and microscopic studies of tissues (lungs, kidneys, myocardium, brain, liver, spleen) of 28 people with drug overdoses involving opioids who died outside hospitals during the same period. The preparations were examined using an Olympus CX 41 microscope in transmitted light, at magnifications of 40, 100, and 400 times.

Results. Clinical, functional and laboratory tests carried out in the hospital's admissions department and in the intensive care unit revealed the following pathological conditions: cerebral coma, brain edema – 158 (96.3 %); respiratory failure – 73 cases (44.5 %); liver failure – 23 (13.4 %); kidney failure, including anuria – 14 (8.5 %); syndrome of prolonged compression of soft tissues and rhabdomyolysis – 9 (5.4 %); cardiopulmonary failure, including pulmonary edema – 19 (11.5 %); the presence of thrombophlebitis, purulent wounds, sepsis – 24 (14.6 %). According to examination data, toxicological anamnesis, and information from patients' relatives, the structure of concomitant pathology was determined in accordance with ICD-10 codes. According to the data of sectional and histological studies, in 89 cases (54.2 %), changes characteristic of a systemic inflammatory reaction and a chronic inflammatory process, including sepsis, were detected. The results of clinical and pathohistological studies show that drug users have various concomitant pathologies of many organs and systems (lungs, heart, liver, kidneys, etc.), which increases the toxic effect of drugs and conditions the features of tonatogenesis.

Conclusions. The study of clinical and histological parallels in cases of sudden death due to drug overdoses will allow us to increase the level of our knowledge about the mechanisms of tonatogenesis and contribute to the determination of effective measures to prevent premature mortality of the population.

Keywords: drugs, overdose, mortality, lethality, forensic medicine.

 

ПЕРЕЛІК ВИКОРИСТАНОЇ ЛІТЕРАТУРИ / REFERENCES

1. European Monitoring Center for Drugs and Drug Addiction (EMCDDA). European Drug Report 2021: Trends and Developments. Electronic resource. URL: https://www.emcdda.europa.eu/publications/edr/trends-developments/2021_en.

2. World Drug Report 2018 (United Nations publication, Sales No. E.18.XI.9). Drugs and age. Drugs and associated issues among young people and older people. Electronic resource. URL: https://www.unodc.org/wdr2018/prelaunch/WDR18_Booklet_4_YOUTH.pdf

3. Looking back on 25 years of annual reporting on the drugs problem in Europe. European Monitoring Centre for Drugs and Drug Addiction, 2020. Electronic resource. URL: https://www.emcdda.europa.eu/publications/brochures/25- years-annual-reporting_en. doi:10.2810/199193.

4. European Drug Report 2020: Trends and Developments. European Monitoring Centre for Drugs and Drug Addiction (2020), Publications Office of the European Union, Luxembourg. Electronic resource. URL: https://www.emcdda.europa.eu/publications/edr/trendsdevelopments/2020_en. doi:10.2810/420678.

5. Degenhardt L, Bucello C, Mathers B, Briegleb C, Ali H, Hickman M, et al. Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies: mortality among opioid users. Addiction. 2011;106:32–51.

6. Degenhardt L, Larney S, Randall D, Burns L, Hall W. Causes of death in a cohort treated for opioid dependence between 1985 and 2005: mortality among opioid-dependent people. Addiction. 2014;109:90–9.

7. Pierce M, Bird S, Hickman M, Millar T. National record linkage study of mortality for a large cohort of opioid users ascertained by drug treatment or criminal justice sources in England, 2005–2009. Drug Alcohol Depend. 2015;146:17–23.

8. Office for National Statistics. 2018. Deaths Related to Drug Poisoning in England and Wales: 2017 Registrations.

9. Aldridge R, Story A, Hwang S, Nordentoft M, Luchenski S, Hartwell G, et al. Morbidity and mortality in homeless individuals, prisoners, sex workers, and individuals with substance use disorders in high-income countries: a systematic review and meta-analysis. Lancet. 2018;391:241–50.

10. Gao L, Robertson J, Bird S. Non-drug-related and opioidspecific causes of 3262 deaths in Scotland’s methadoneprescription clients, 2009–2015. Drug Alcohol Depend. 2019;197:262–70.

11. Merrall E, Bird S, Hutchinson S. A record linkage study of hospital episodes for drug treatment clients in Scotland, 1996–2006. Addict. Res. Theory. 2013;21:52–61.

12. Merrall E, Bird S, Hutchinson S. Mortality of those who attended drug services in Scotland 1996–2006: record-linkage study. Int. J. Drug Policy. 2012;23:24–32.

13. Vandenbroucke J, von Elm E, Altman D, Gøtzsche P, Mulrow C, Pocock S, et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Int. J. Surg. 2014;12:1500–24.

14. King N, Harper S, Young M. Use of relative and absolute effect measures in reporting health inequalities: structured review. BMJ. 2012;345:e5774.

15. Dettmeyer R. Forensic Histopathology: Fundamentals and Perspectives, 2nd ed.; Springer: Cham, Switzerland, 2018. ­593 pages.

16. Osborn M, Howard M, Morley S, McCarthy H. Guidelines on Autopsy Practice: Autopsy When Drugs or Poisoning May Be Involved; The Royal College of Pathologists: London, UK, 2018. URL:https://www.aaptuk.org

17. Skopp G. Preanalytic aspects in postmortem toxicology. Forensic Sci. Int. 2004;142:75–100.

 

Стаття надійшла до редакції 01.02.2023

The article was received by the editors on February, 1st, 2023